Viread and Paleness - a phase IV clinical study of FDA data

Summary:

Paleness is reported as a side effect among people who take Viread (tenofovir disoproxil fumarate), especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years also take Sustiva, and have Epilepsy.

The phase IV clinical study analyzes which people have Paleness when taking Viread. It is created by eHealthMe based on reports of 51,434 people who have side effects when taking Viread from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Paleness?

Paleness (unusual lightness of skin colour) is found to be associated with 1,563 drugs and 2,117 conditions by eHealthMe. Check the latest studies of Paleness.

On Jul, 27, 2026

51,434 people reported to have side effects when taking Viread.
Among them, 12 people (0.02%) have Paleness.

Among these 12 people:

How long have people been on Viread when they have Paleness? *

What is the gender of people who have Paleness when taking Viread? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Paleness when taking Viread? *

What are other drugs people take besides Viread? *

What are other side effects people have besides Paleness? *

Arrhythmias (irregular heartbeat): 5 people, 41.67%
Haemolytic Anaemia (anaemia due to haemolysis): 5 people, 41.67%
Cardiac Arrest: 5 people, 41.67%
Tachypnea: 5 people, 41.67%
Confusional State: 5 people, 41.67%
Confusion: 4 people, 33.33%
Acute Kidney Failure: 3 people, 25.00%
Depressed Level Of Consciousness: 3 people, 25.00%
Hepatomegaly (abnormal enlargement of the liver): 3 people, 25.00%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 3 people, 25.00%

What are the existing conditions these people have? *

Hepatitis C: 3 people, 25.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 25.00%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 8.33%
Pain: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 8.33%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and have Paleness?

- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viread:

Viread (51,542 reports)

Paleness treatments and more:

Paleness (34,670 reports)

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paleness:

Paleness (1,563 drugs)

Browse all the conditions that are associated with Paleness:

Paleness (2,117 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate (the active ingredients of Viread) and Viread (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.